Medicine. Saint Petersburg hosted the 4th Nuclear Medicine 2025 Congress. Organized with Rosatom’s support, the event brought together over 500 professionals from Russia and other countries. Delegates emphasized the importance of cooperation between research centers, medical organizations, and manufacturers in developing every aspect of nuclear medicine. According to experts, 62 radiopharmaceuticals are registered in Russia, with only four being foreign-made. They serve primarily for diagnostics, but the number of therapeutic drugs for treating severe diseases is growing. About 220 Russian medical centers use radionuclides in the diagnostics and treatment of oncological and non-oncological diseases. “Activities of Rosatom’s Research Division are not limited to reactor-based isotope production. We cover the entire supply chain, from fundamental science to commercial sales,” says Alexander Tuzov, First Deputy CEO of Rosatom Science.